Side-by-side comparison of AI visibility scores, market position, and capabilities
E-prescribing, medication history, and patient safety platform processing hundreds of millions of Rx transactions annually. Rockville MD; founded 2000; embedded in hundreds of EHR and clinical workflow platforms; EPCS compliance and medication history retrieval improve prescribing safety for 500K+ providers.
DrFirst is a health IT company that has been at the forefront of e-prescribing and medication management since its founding in 2000. Headquartered in Rockville, Maryland, DrFirst provides e-prescribing for controlled substances (EPCS), medication history retrieval, clinical decision support, and patient medication adherence tools to hospitals, physician practices, long-term care facilities, and health IT vendors. The company processes hundreds of millions of prescription transactions annually and is embedded in a wide range of EHR and clinical workflow platforms through its APIs and SDK integrations.\n\nDrFirst's flagship EPCS solution was among the earliest to achieve DEA compliance for electronic prescribing of controlled substances, a capability that has become essential as regulatory requirements and clinical adoption have expanded across all states. The company's medication history service aggregates pharmacy and payer claims data to give providers a more complete view of a patient's actual medication use, supporting medication reconciliation at transitions of care and reducing adverse drug events. DrFirst also offers Backline, a secure clinical communication platform for care team messaging.\n\nDrFirst occupies a specialized but critical position in the health IT ecosystem, providing medication-related infrastructure that EHR vendors embed in their platforms rather than build independently. This embedded model gives DrFirst broad distribution across the provider market and creates sticky, long-term customer relationships. The company has invested in expanding its clinical intelligence capabilities, including AI-driven prior authorization for specialty medications and smart alerts that surface relevant clinical guidance at the point of prescribing.
Open-source offline-first API client with git-native Bru file storage; solo-founded, declined 8 VC offers, competing with Postman and Insomnia for developers seeking privacy-respecting local API testing tooling.
Bruno is an open-source API client and testing tool — a lightweight, offline-first, git-friendly alternative to Postman and Insomnia — enabling developers to explore, test, and document APIs with collections stored as plain-text Bru files in the project filesystem rather than in cloud-synced proprietary formats. Created by a solo founder in 2022 and growing to a 9-person team by late 2024, Bruno operates with an unusual philosophy: the founder publicly declined 8 venture capital offers to preserve product freedom and build toward profitability, with the core Bruno client remaining free and open-source (MIT license) while the Golden Edition provides enterprise features for commercial revenue. Pro and Ultimate paid editions launched in 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.